PLX PHARMA INC's ticker is PLXP and the CUSIP is 72942A107. A total of 47 filers reported holding PLX PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $10,295 | -60.4% | 79,132 | -50.0% | 0.00% | – |
Q4 2022 | $25,972 | -49.1% | 158,264 | +100.0% | 0.00% | – |
Q3 2022 | $51,000 | -73.4% | 79,132 | 0.0% | 0.00% | – |
Q2 2022 | $192,000 | -40.0% | 79,132 | 0.0% | 0.00% | – |
Q1 2022 | $320,000 | -46.7% | 79,132 | +5.6% | 0.00% | – |
Q4 2021 | $600,000 | -58.3% | 74,940 | +0.5% | 0.00% | – |
Q3 2021 | $1,439,000 | +46.5% | 74,540 | +4.8% | 0.00% | – |
Q2 2021 | $982,000 | – | 71,140 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MSD Partners, L.P. | 1,875,000 | $4,556,000 | 0.28% |
Ground Swell Capital, LLC | 48,931 | $119,000 | 0.22% |
Park West Asset Management LLC | 1,473,218 | $3,580,000 | 0.20% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 62,673 | $152,000 | 0.07% |
Eidelman Virant Capital | 27,000 | $63,000 | 0.04% |
MBL Wealth, LLC | 52,000 | $126 | 0.03% |
O'Brien Greene & Co. Inc | 22,340 | $54,000 | 0.02% |
SHUFRO ROSE & CO LLC | 56,800 | $138,000 | 0.01% |
GW&K Investment Management, LLC | 424,921 | $1,033,000 | 0.01% |
EXANE DERIVATIVES | 6,575 | $15,974,000 | 0.01% |